LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 29 filers reported holding LYRA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,167,210 | -4.7% | 2,856,064 | +0.1% | 0.00% | 0.0% |
| Q2 2023 | $11,723,685 | +44377.0% | 2,852,478 | +22300.5% | 0.00% | – |
| Q1 2023 | $26,359 | -67.9% | 12,734 | -51.4% | 0.00% | – |
| Q4 2022 | $82,196 | -55.8% | 26,177 | -29.5% | 0.00% | – |
| Q3 2022 | $186,000 | +220.7% | 37,136 | +180.2% | 0.00% | – |
| Q4 2021 | $58,000 | -62.8% | 13,252 | -31.6% | 0.00% | – |
| Q2 2021 | $156,000 | -94.6% | 19,381 | -92.4% | 0.00% | -100.0% |
| Q2 2020 | $2,901,000 | – | 255,794 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,777,251 | $3,572,275 | 0.74% |
| Perceptive Advisors | 9,146,730 | $18,384,927 | 0.54% |
| PURA VIDA INVESTMENTS, LLC | 1,996,972 | $4,013,914 | 0.41% |
| VR Adviser, LLC | 924,170 | $1,857,582 | 0.36% |
| Nantahala Capital Management | 2,220,830 | $4,463,868 | 0.34% |
| Ikarian Capital, LLC | 343,685 | $711,427 | 0.16% |
| Soleus Capital Management, L.P. | 592,417 | $1,190,758 | 0.12% |
| Clearline Capital LP | 119,128 | $239,448 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 146,800 | $303,876 | 0.01% |
| Tower Research Capital LLC (TRC) | 9,972 | $20 | 0.00% |